Resources


Advanced




  This area of the site
   requires the
  Acrobat Reader
  and the ability to
  view zipped files.
  Click below to
  download the
   necessary
   software.
  The StuffIt
   software can be
   used for either
   Windows or
   Macintosh.


Download the Adobe Acrobat reader

Download the StuffIt Expander

Download WinZip

 
 
Slide Lecture Programs
2003 Core Curriculum
Impact of vascular biology in treatment of cardiovascular disease
Section III: Neurohormonal strategies in the failing heart
May 3, 2003

The VBWG Core Curriculum 2003 slide lecture compendium Impact of vascular biology in treatment of cardiovascular disease, provides updates on new science and mechanisms of disease, plus implications of recent clinical trials.

Areas of focus:

The material in this section of the slide/lecture program discusses new approaches to the treatment of heart failure with a focus on the following areas:

  • The neurohormonal model of vascular dysfunction in heart failure and implications for treatment
  • Reassessing management of heart failure based on recent clinical trials
  • Confronting misconceptions about ß-blockers and expanding opportunities for CV protection with neurohormonal blockade.

View/Download individual slides (50 Slides)
Need Download Help?
  View Thumbnails  Download  Slides
Heart failure: A challenge to the healthcare delivery system   PPT   PPT  18 - 31
Neurohormonal blockade across the continuum of CV disease: Expanding options for cardioprotection<   PPT   PPT  32 - 50
  Download entire presentation   PPT   PDF All Slides 

Published by Medical Education Consultants, Inc. (MEDCON), on behalf of the University of Florida College of Medicine.

The editorial content of this program does not necessarily reflect the views or recommendations of the University of Florida College of Medicine or AstraZeneca, Aventis Pharmaceuticals Inc, King Pharmaceuticals, Pfizer Inc, Wyeth Pharmaceuticals, or the publisher. The reader is advised to consult the full prescribing information of each product prior to use.

This program was prepared and produced by Medical Education Consultants, Inc, Westport, Connecticut, on behalf of the University of Florida College of Medicine through an unrestricted educational grant provided by AstraZeneca, Aventis Pharmaceuticals Inc, King Pharmaceuticals, Pfizer Inc, and Wyeth Pharmaceuticals.

©2003 Medical Education Consultants, Inc. (MEDCON). All rights reserved.


Home | Literature Update | Journal Link | Resources | Meeting Highlights | Members | About VBWG | Web Links